Portfolio manager exercises NHS (NYS: NHS) rights to buy 7,000 shares at $6.50
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Neuberger High Yield Strategies Fund Inc. portfolio manager Chris Kocinski exercised subscription rights to acquire additional Common Stock. On April 15, 2026, he exercised Rights into 7,000 shares of Common Stock at a final subscription price of $6.50 per share, bringing his direct holdings to 28,000 shares.
The exercised position originated from 21,000 transferable subscription rights, each allowing the purchase of one new share of Common Stock for every three Rights held, as part of a rights offering made to common stockholders of record on March 23, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
21,000 shares exercised/converted
Mixed
2 txns
Insider
Kocinski Chris
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| X | Transferable Subscription Rights | 21,000 | $0.00 | -- |
| X | Common Stock | 7,000 | $6.50 | $46K |
Holdings After Transaction:
Transferable Subscription Rights — 0 shares (Direct, null);
Common Stock — 28,000 shares (Direct, null)
Footnotes (1)
- Neuberger High Yield Strategies Fund Inc. (the "Fund") issued transferable subscription rights ("Rights") to its common stockholders of record as of the close of business on March 23, 2026 (the "Record Date") entitling the holders of these Rights to purchase additional shares of common stock of the Fund (the "Common Stock"). The holders of Common Stock of record on the Record Date ("Record Date Stockholders") were entitled to subscribe for additional shares of Common Stock at a discount to the market price of the Common Stock. The Fund distributed to Record Date Stockholders one Right for each share of Common Stock held on the Record Date. The Rights entitle their holders to purchase one new share of Common Stock for every three Rights held (1 for 3). The subscription period commenced on the Record Date and expired on April 15, 2026. The final subscription price of $6.50 per share of Common Stock was determined based upon the terms of the offer. The Common Stock subscribed for will be issued after receipt of all stockholder payments. Fractional shares of Common Stock will not be issued.
Key Figures
Shares acquired: 7,000 shares
Subscription price: $6.50 per share
Rights exercised: 21,000 rights
+3 more
6 metrics
Shares acquired
7,000 shares
Common Stock acquired via rights exercise on April 15, 2026
Subscription price
$6.50 per share
Final subscription price for Common Stock in rights offering
Rights exercised
21,000 rights
Transferable subscription rights exercised into Common Stock
Post-transaction holdings
28,000 shares
Total Common Stock directly held after exercise
Rights ratio
1-for-3
One new share purchasable for every three rights held
Record date
March 23, 2026
Date determining stockholders eligible for subscription rights
Key Terms
transferable subscription rights, Record Date, subscription period, final subscription price, +1 more
5 terms
transferable subscription rights financial
"issued transferable subscription rights ("Rights") to its common stockholders of record"
Record Date financial
"common stockholders of record as of the close of business on March 23, 2026 (the "Record Date")"
The record date is the specific day when a company determines which shareholders are eligible to receive a dividend or participate in an upcoming vote. It’s like a cutoff date; if you own the stock on that day, you get the benefits or voting rights. This date matters because it decides who qualifies for certain company benefits.
subscription period financial
"The subscription period commenced on the Record Date and expired on April 15, 2026."
A subscription period is the set number of days when investors can sign up to buy newly offered securities, such as shares or bonds, at a specified price. Think of it like a limited-time sale window: if you want to join the offering you must commit during that window, and the number of applicants can affect how many units each investor receives and the final price outcome. For investors, it matters because timing, demand and allocation during this period directly influence potential ownership stake and short-term position value.
final subscription price financial
"The final subscription price of $6.50 per share of Common Stock was determined"
FAQ
What did Chris Kocinski do in this Form 4 for NHS?
Chris Kocinski exercised transferable subscription rights to acquire 7,000 shares of Neuberger High Yield Strategies Fund Inc. Common Stock at $6.50 per share, increasing his direct holdings to 28,000 shares following the transaction reported on April 15, 2026.
What was the subscription price in the NHS rights offering?
The final subscription price was $6.50 per share of Common Stock. This price was determined under the offer’s terms, allowing record date stockholders to purchase additional NHS shares at a discount to the prevailing market price during the subscription period.
How did the transferable subscription rights for NHS work?
Record date stockholders received one Right for each share owned on March 23, 2026. Every three Rights entitled the holder to purchase one new share of Common Stock on a 1-for-3 basis, subject to the final $6.50 per share subscription price during the offer.
What happened to Chris Kocinski’s NHS holdings after exercising rights?
After exercising subscription rights into 7,000 new shares, Chris Kocinski directly held 28,000 shares of Neuberger High Yield Strategies Fund Inc. Common Stock. The derivative position in transferable subscription rights was fully exercised, leaving no remaining rights reported in this filing.
When did the NHS subscription period begin and end?
The subscription period began on the March 23, 2026 record date and expired on April 15, 2026. During this window, eligible stockholders could use their transferable subscription rights to subscribe for additional Common Stock at the $6.50 per share subscription price.